chr7:55174014:> Detail (hg38) (EGFR)

Information

Genome

Assembly Position
hg19 chr7:55,241,707-55,241,708 
hg38 chr7:55,174,014-55,174,015

HGVS

Type Transcript Protein
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

[No Data.]

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
lung adenocarcinoma Erlotinib B Predictive Supports Sensitivity/Response Somatic 2 26773740 Detail
lung non-small cell carcinoma Gefitinib,Erlotinib B Predictive Supports Sensitivity/Response Somatic 3 21531810 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
In a meta-analysis of 7 clinical trials of erlotinib, 10/24 patients with Exon 18 mutations harbored... CIViC Evidence Detail
EGFR G719 mutations have been associated with increased sensitivity to first generation EGFR tyrosin... CIViC Evidence Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
Genome
hg38
Position
chr7:55,174,014-55,174,015
Variant Type
snv
Variant (CIViC) (CIViC Variant)
G719
Transcript 1 (CIViC Variant)
ENST00000275493.2
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/718
Genome browser